5-Amino-1MQ
Research metabolism compound — not FDA-approved.
What it's for
Research metabolism compound — not FDA-approved.
What it's for
5-Amino-1MQ is a research compound (not a classic peptide chain) studied for blocking an enzyme called NNMT involved in cell metabolism.
What it does for the body
It appears in fat-metabolism and NAD-related research discussions. It is not FDA-approved for weight loss or longevity. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
By blocking NNMT in research models, cells may shift metabolic signaling. Think of jamming a side-path enzyme — experimental only. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.
Research context
Bottom line for readers: 5-Amino-1MQ is best treated as a research-interest topic. Early papers can be fascinating; they are not a green light for self-experimentation.
Studied for (literature interest)
- Digestive research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: 5-Amino-1MQ — FDA.gov search
- ClinicalTrials.gov search: 5-Amino-1MQ — U.S. clinical trials registry
- Drugs@FDA search: 5-Amino-1MQ — FDA drug database (if approved)
- PubMed search: 5-Amino-1MQ — NCBI PubMed
- PubMed Central search: 5-Amino-1MQ — NCBI PMC